93 results
Page 5 of 5
DEFA14A
k9vc5n6w4gq
6 Apr 20
Additional proxy soliciting materials
4:53pm
DEF 14A
ut00e u6hg2oef
6 Apr 20
Definitive proxy
4:52pm
8-K
EX-99.1
7gpfofpf3ro k64y
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
8-K
zalp7kqwqd2
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
10-K
ycowlx ivkfeicr
26 Mar 20
Annual report
4:08pm
8-K
EX-99.1
gcgkys 0ib
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
8-K
EX-99.1
cqq85l
12 Feb 20
Vir Biotechnology Identifies Two Antibodies That Bind to The Spike Protein of
5:02pm
8-K
EX-99.1
fj2ms lhzao6
19 Nov 19
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:05pm
424B4
qxxx8iexn3spkc4
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
yin98
30 Sep 19
IPO registration (amended)
6:12am
S-1
lfqjuonjyakh 34hjv8d
3 Sep 19
IPO registration
4:40pm
DRS/A
zep7qhj9 dkwc9e
7 Aug 19
Draft registration statement (amended)
12:00am
DRS
bz76vz
27 Jun 19
Draft registration statement
12:00am